Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia.

about

Clinical significance of microRNAs in chronic and acute human leukemia Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers.MiRNA Dysregulation in Childhood Hematological Cancer

P2860

Q26749533-ABCCEF27-33FB-4550-8F15-B418B454F2B7 Q42365364-1EB8BD4D-4577-40D0-8812-074E61938169 Q58753107-B7D5B543-FFD8-4FB4-8104-5BB4F8A1EF5A

P2860

Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia.

Item

http://www.wikidata.org/entity/Q46924932

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Clinical impact of circulating ...... acute lymphoblastic leukemia.

@en

Clinical impact of circulating ...... acute lymphoblastic leukemia.

@nl

type

Item

label

Clinical impact of circulating ...... acute lymphoblastic leukemia.

@en

Clinical impact of circulating ...... acute lymphoblastic leukemia.

@nl

prefLabel

Clinical impact of circulating ...... acute lymphoblastic leukemia.

@en

Clinical impact of circulating ...... acute lymphoblastic leukemia.

@nl

P1476

Clinical impact of circulating ...... acute lymphoblastic leukemia.

@en

P2093

Menha Swellam

http://www.w3.org/2001/XMLSchema#string

P2860

miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice

Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia

Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53

MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.

Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia.

Evolution of coding and non-coding genes in HOX clusters of a marsupial.

Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis.

MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia.

P2888

s13277-016-4948-7

P304

10571-10576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-016-4948-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nashwa El-Khazragy

P577

2016-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26857279

http://www.w3.org/2001/XMLSchema#string

P921

microRNA

Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia.

about

P2860

P2860

Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921